Skip to main content

How overdose of paracetamol hits kids

“Anxious mothers are feeding children excessive dosages”

“Overdose can happen more easily in children”

‘Drops' version mistaken for syrup




Even love is valuable only if it is given in the right dosage. Overdoses of drugs, specially the common paracetamol, need not be dangerous in adults, but can lead to serious complications, including liver failure, in children.

Over the past few weeks, with viral and flu infections rampant, a number of children have been admitted to the intensive care units, not for treatment of the primary illness, but for paracetamol poisoning. Janani Sankar, senior consultant, Kanchi Kamakoti CHILDS Trust Hospital, says kids come in with multi-organ failure, and while most of them could be saved, some have been beyond help as they have come too late.

“Two types of overdosing can occur: one is accidental, when the children drink up syrup because it is tasty; or two doses are taken by mistake. The other is what we are commonly seeing now: mothers with extreme anxiety feeding their children excessive dosages of paracetamol in order to bring the fever down,” Dr. Janani adds.

In a season when dengue cases are numerous, the course of the disease itself involves very high fever for several days. Mothers, in their anxiety to reduce the fever end up giving more than the recommended dosage, she says.

“In children, paracetamol overdosing can happen more easily than in adults. Doses are calibrated with body weight, and in children, even a little extra may be too much,” P. Ramachandran, director, Institute of Child Health, says. He adds that a number of private hospitals are reporting such cases increasingly.

Different values

Parents sometimes do not check the dosage of the drugs they are giving the child, as they are available in different values across different brands.

“There is the Double Strength version which they buy instead of the regular dose. With the increase in the number of dosages per day, the chances that it becomes too much for the child is high,” Rex Sargunam, senior paediatrician, explains.

Yet another complication arises because parents sometime mistake the ‘drops' version for the syrup. Deepa Hariharan, neonatologist at Sooriya Hospital says, “We had two cases recently of really sick children, where parents had bought drops instead of syrup.”

In the drops, there is 100 mg of drug in one ml while with the syrup, there is 125 mg in five ml.

“When we ask the parent to give 5 ml of the syrup four times a day, we intend a dose of 500 mg. Instead the parent buys the drops, and lands up dosing the child with 2000 mg of paracetamol,” Dr. Deepa adds.

In children, the liver is not very mature and therefore this overdose can be dangerous.

Dr. Janani cautions parents, “Do not be extraordinarily anxious and overdose the child. The paediatrician's recommended dosage must be stuck to at all times.”

Dr. Ramachandran also adds that parents and physicians should suspect and look for signs of paracetamol poisoning when a child is ill. “Initially there will be vomiting, maybe with some blood, the child will feel drowsy and will have liver damage within one to three days. Parents and physicians should watch out for this,” he says.

Laboratory tests to confirm unacceptable paracetamol levels are available and once the diagnosis is confirmed, treatment can be started at once.

This article is from The Hindu

Comments

Popular posts from this blog

Indian government outlines policies on drug pricing to favor poorer patients, and increase clinical trials

The Indian government is looking to review the existing drug price control measures in order to make medicines more affordable in the country, and at increasing the number of clinical trials taking place in the country, reports The Pharma Letter's India correspondent. In a parallel move, the Health Ministry is also preparing a framework for public private partnership to tackle the menace of non-communicable diseases in the country, In a move that could potentially result in affordable Medicare and health security moving to a larger section of the population, the government is considering a rash of policy measures in favor of poor patients. Talks are also on in government circles to abolish clinical trials on proven drugs that have been approved and marketed for at least two years in the European Union, United States, UK, Australia, Canada and Japan. A draft proposal in this regard has been prepared by the Health Ministry. If instituted, it would reduce the time taken to introduce n...

The polypill: Medicine's magic bullet

The capsule costs pennies, contains a simple cocktail of medicines, and halves the number of strokes and heart attacks. Doctors want to hand it out in the first mass medication for the middle-aged in Britain. So why are the big drug companies so uninterested? The magic bullet, containing five medicines in a single capsule, sharply reduced cholesterol and blood pressure levels and has the potential to "halve cardiovascular events in average middle-aged individuals", the researchers say. The finding is a major boost for a medication with huge potential against the worldwide epidemic of heart disease and stroke. Doctors say that, if further trials prove successful, all men aged over 50 and women aged over 60 should be offered the pill in what would be the first example of mass medication for the middle-aged in Britain. Yet no Western pharmaceutical company has shown interest in developing the so-called polypill because it does not promise big profits. It would sell for pennies b...

Delay in 'Made in India' chikungunya vaccine, researchers seek government intervention

India offers a rare ray of hope for an indigenously-made vaccine against chikungunya, but delay in finding volunteers is impeding its development.   With chikungunya spreading very fast in the country, researchers are seeking urgent government intervention for speedy completion of the vital clinical trials.  Chikungunya is a dreaded infection transmitted through the bite of the mosquito. There is no known cure and till date, there is no vaccine anywhere in the world again ..  The novel vaccine candidate against chikungunya crossed a big hurdle last year when Bharat Biotech, a Hyderabad-based vaccine pioneer, got permission to start human trials and the first human subjects received the vaccine a few months ago.  The company says the phase-I trials will "evaluate the vaccine's safety, tolerability and immunogenicity. The placebo controlled study involving 60 healthy volunteers would test escalating doses of the vaccine in prime-boost regimen".  Continue reading here:  Sour...